HeartBeam (Nasdaq:BEAT) announced today that it expanded its product portfolio to add arrhythmia detection capabilities to wearables. Santa Clara, California-based HeartBeam said in a news release that it aims to serve the growing cardiac device wearable market. The pipeline advancement allows for the addition of arrhythmia detection capabilities for AFib and other arrhythmia monitoring. The […]
HeartBeam
HeartBeam picks up patent for 12-lead ECG patch
HeartBeam (Nasdaq:BEAT) announced today that the U.S. Patent and Trademark Office issued a patent for its 12-lead electrocardiogram (ECG) patch. Santa Clara, California–based HeartBeam designed its ECG patch monitor for detecting acute coronary syndrome (ACS) and cardiac arrhythmia. The company said in a news release that the granted patent builds on its portfolio, enabling 12-lead […]
HeartBeam submits heart attack diagnostic platform for FDA 510(k) clearance
HeartBeam (Nasdaq:BEAT) announced today that it submitted a 510(k) clearance application to the FDA for its HeartBeam AIMI platform. Santa Clara, California-based HeartBeam designed its proprietary electrocardiogram (ECG) technology for use in diagnosing heart attacks. The company’s HeartBeam AIMI platform assists healthcare professionals in identifying patients who present with chest pain to facilitate rapid detection […]
HeartBeam picks Triple Ring to co-develop portable heart attack detector
HeartBeam (Nasdaq: BEAT) said today that it has signed a professional services agreement with Triple Ring Technologies to help develop and design its personal, portable heart attack detector. Santa Clara, California-based HeartBeam said it plans to submit what it calls a “telehealth complete solution 3D vector electrocardiogram (ECG) collection device” for FDA 510(k) clearance in […]